CureVac N.V. (NASDAQ:CVAC) traded at $79.69 at last check on Friday, Nov 20, making an upward move of 5.97% on its previous day’s price.
Looking at the stock we see that its previous close was $75.2 and the beta (5Y monthly) reads 0 with the day’s price range being $76.80 – 79.93. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, CVAC has a high of $85.68 and a low of $36.15. The company’s stock has gained about 62.4% over that past 30 days.
Based on estimates by 5 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 2 have rated the CureVac N.V. (CVAC) stock as a Hold, while 3 rate it as a Buy. None analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.
Let’s briefly compare CureVac (CVAC) stock to its peers. We find that today’s price change of +5.97% and 0% over the past 12 months for CVAC competes that of Bristol-Myers Squibb Company (BMY), which has seen its stock price fall -0.77% in the latest trading session and is +8.37% over the last one year. Another of its peers Amgen Inc (AMGN) has dropped -0.67% today, but is -2.04% down over the past year, while Gilead Sciences Inc (GILD) is also up 5.97% yet its price remains in the red at 0% over the same period. Bristol-Myers has a P/E ratio of 0 compared to CureVac’s 0 and Amgen’s 17.99. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to CureVac N.V. (NASDAQ:CVAC), we note that the average 3-month trading volume was 767.59 Million, while that of the preceding 10-day period stands at 839.75 Million. Current shares outstanding are 177.97 Million.
According to data from Thomson Reuters, insiders hold 58.63% of the company’s shares while institutions hold 21.09%. The data shows that short shares as of October 29, 2020, stood at 1.11 Million at a short ratio of 2.7. This represents a 0.62% Short interest in Shares outstanding on October 29, 2020. Shares short dropped in October from the previous month at 1.13 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +42.56% up in year-to-date price movement.